A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (2) [Extension of Study 156-05-002]

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Autosomal Dominant Polycystic Kidney Disease

Interventions

DRUG

OPC-41061

Repeated oral administration at doses of 15 mg twice daily (morning and evening)

Trial Locations (1)

Kanto Region